A detailed history of Prio Wealth Limited Partnership transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 30,829 shares of BMY stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
30,829
Previous 31,983 3.61%
Holding current value
$1.26 Million
Previous $1.64 Million 1.83%
% of portfolio
0.05%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $55,368 - $62,777
-1,154 Reduced 3.61%
30,829 $1.67 Million
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $5,090 - $6,074
-105 Reduced 0.33%
31,983 $1.64 Million
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $2,547 - $2,848
44 Added 0.14%
32,088 $1.86 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $25,101 - $27,871
-394 Reduced 1.21%
32,044 $2.05 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1.21 Million - $1.37 Million
-18,444 Reduced 36.25%
32,438 $2.25 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $361,916 - $428,560
-5,285 Reduced 9.41%
50,882 $0
Q3 2022

Feb 27, 2023

SELL
$0.13 - $76.84 $730 - $431,610
-5,617 Reduced 10.06%
50,232 $3.57 Million
Q2 2022

Feb 27, 2023

BUY
$72.62 - $79.98 $360,703 - $397,260
4,967 Added 9.76%
55,849 $4.3 Million
Q1 2022

Feb 21, 2023

BUY
$61.48 - $73.72 $297,317 - $356,509
4,836 Added 9.5%
55,718 $4.07 Million
Q4 2021

Feb 17, 2022

SELL
$53.63 - $62.52 $40,276 - $46,952
-751 Reduced 1.32%
56,167 $3.5 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $15,798 - $18,505
267 Added 0.47%
56,918 $3.37 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $232,410 - $253,094
-3,754 Reduced 6.21%
56,651 $3.79 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $259,019 - $291,320
-4,365 Reduced 6.74%
60,405 $3.81 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $9,700 - $10,992
168 Added 0.26%
64,770 $4.02 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $8,614 - $9,546
-150 Reduced 0.23%
64,602 $3.9 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $55,039 - $64,346
1,004 Added 1.57%
64,752 $3.81 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $43,987 - $63,923
-948 Reduced 1.47%
63,748 $3.55 Million
Q4 2019

Feb 10, 2020

SELL
$49.21 - $64.19 $241,178 - $314,595
-4,901 Reduced 7.04%
64,696 $4.15 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $40,545 - $48,073
948 Added 1.38%
69,597 $3.53 Million
Q2 2019

Jul 18, 2019

SELL
$44.62 - $49.34 $71,392 - $78,944
-1,600 Reduced 2.28%
68,649 $3.11 Million
Q1 2019

May 03, 2019

SELL
$45.12 - $53.8 $138,428 - $165,058
-3,068 Reduced 4.18%
70,249 $3.35 Million
Q4 2018

Feb 06, 2019

BUY
$48.76 - $63.23 $8,776 - $11,381
180 Added 0.25%
73,317 $3.81 Million
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $165,514 - $186,687
-2,999 Reduced 3.94%
73,137 $4.54 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $14,855 - $18,516
-294 Reduced 0.38%
76,136 $4.21 Million
Q1 2018

Apr 17, 2018

BUY
$59.92 - $68.98 $4.58 Million - $5.27 Million
76,430 New
76,430 $4.83 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86.9B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.